Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Sarah McKeown, a second-year DPhil on the Evidence-Based Medicine Programme, writes about her experience of clinical studies in low-resource settings and studying differences in access to cancer medication between patients covered by England’s NHS and the U.S. Medicare program.

Sarah McKeown headshot
Load More